Mortality (measured at 30 days) · critically ill adult patients
It is very uncertain whether early enteral nutrition changes mortality (measured at 30 days) compared with delayed enteral nutrition (very low certainty).
1 finding from 1 review
In‐hospital all‐cause mortality · critically ill term and late preterm infants
Late parenteral nutrition may leads to lower in‐hospital all‐cause mortality compared with early parenteral nutrition (low certainty).
1 finding from 1 review
Neonatal mortality · critically ill term and late preterm infants
Late parenteral nutrition may leads to lower neonatal mortality (within 28 days of birth) compared with early parenteral nutrition (low certainty).
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes mortality compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether postoperative enteral nutrition (Osmolite) via nasojejunal tube changes mortality compared with postoperative parenteral nutrition (PN) (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
Enteral nutrition may leads to lower all‐cause mortality compared with no intervention (low certainty).
1 finding from 1 review
All‐cause mortality
It is very uncertain whether postoperative parenteral nutrition changes mortality compared with oral nutrition alone (very low certainty).
1 finding from 1 review
Mortality (timing of outcome measurement unclear) · critically ill adult patients
It is very uncertain whether early enteral nutrition with supplemental parenteral nutrition (SPN) changes mortality (timing of outcome measurement unclear) compared with delayed enteral nutrition with SPN (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
It is very uncertain whether fibre‐enriched enteral nutrition changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
All‐cause mortality · lower gastrointestinal surgery
Early enteral nutrition within 24 hours of lower gastrointestinal… showed no clear difference in mortality compared with later commencement (low certainty).
1 finding from 1 review
All‐cause mortality · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes participants with acute…
Enteral showed no clear difference in mortality compared with parenteral nutrition (low certainty).
1 finding from 1 review
All‐cause mortality · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes participants with acute…
Enteral showed no clear difference in mortality compared with enteral and parenteral nutrition (low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
Enteral may leads to lower mortality compared with parenteral nutrition (low certainty).
1 finding from 1 review
Mortality [within first 10 weeks after liver transplantation] · adult patients after liver transplantation.
Standard parenteral nutrition may leads to lower mortality [within first 10 weeks after liver transplantation] compared with standard isotonic intravenous glucose solution (low certainty).
1 finding from 1 review
Mortality [within first 10 weeks after liver transplantation] · adult patients after liver transplantation.
Parenteral nutrition plus branched‐chain‐amino‐acid‐enriched formula showed no clear difference in mortality [within first 10 weeks after liver transplantation] compared with standard isotonic intravenous glucose solution (low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
Immunonutrition may leads to lower all‐cause mortality compared with control (low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
It is very uncertain whether probiotics changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether more frequent (less than eight hours) changes mortality (at the end of compared with less frequent (eight hours or greater) monitoring of gastric… (very low certainty).
1 finding from 1 review